News | November 03, 2021
Covaxin shelf-life extended to 12 months from the date of manufacture
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
The combined entity will have 12 hospitals with 3,666 beds
Support from DFC will help produce one billion vaccine doses by the end of 2022
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
The Pune centre expands its presence beyond Bangalore and Hyderabad
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
Subscribe To Our Newsletter & Stay Updated
